Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data

NCT07607002 is registered in ClinicalTrials.gov with Arbor Research Collaborative for Health as lead sponsor.

NCT NCT07607002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07607002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data
Lead sponsor
Arbor Research Collaborative for Health
Phase
Observational
Overall status
Completed
Start date
January 1, 1996
Completion date
December 31, 2023
Enrollment
70,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

igan - iga nephropathy